Rapidemic
PrivateLast Round
Grant
Sep 25, 2025
Total Funding Raised
$811,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rapidemic is a diagnostic equipment company that develops ultrarapid, power-free molecular diagnostic tests for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rapidemic Comparables
Compare Rapidemic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExGen Dx | 88% | |
| Fuse Diagnostics | 82% | |
| Selfdiagnostics | 81% |
Rapidemic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 25, 2025 | ||||
| Grant | Jun 10, 2023 | ||||
| Grant | Jan 14, 2023 | ||||
| Grant | Jan 1, 2023 | ||||
| Pre Seed | Dec 13, 2021 |
Key People
Founding team and executive leadership
Rapidemic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherlands Organization for Scientific Research | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Graduate Entrepreneur | Pre Seed |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 250% MoM, reaching 2.2K.
- Aug 21, 2026
Monthly visitors grew 399% MoM.
Rapidemic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rapidemic's valuation, stock price, and market status.
Is Rapidemic a public or private company?
Rapidemic is a private company.
What is the current stock price of Rapidemic?
Rapidemic is a private company, so its shares have no public market price. Caplight tracks Rapidemic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rapidemic worth (valuation)?
Valuation information for Rapidemic is not publicly available.
Can I buy Rapidemic stock?
Rapidemic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rapidemic's last funding round?
Rapidemic's most recent funding round was Grant on September 25, 2025.
Who are the main investors in Rapidemic?
Key investors in Rapidemic include Netherlands Organization for Scientific Research, Bill & Melinda Gates Foundation, Graduate Entrepreneur, Women TechEU.
Will Rapidemic IPO soon?
No public IPO plans have been announced for Rapidemic.
How can I track Rapidemic secondary market activity?
Caplight tracks bids, offers, and trades in Rapidemic's shares on secondary markets.